FERTILITY-SPARING IN CANCER PATIENTS
Loading...
Date
Authors
Karakaş, Sema
Kaya, Cihan
Schäfer, Sebastian Daniel
Mikuš, Mislav
Terzic, Milan
Abdullaev, Bekhzod
Andrisani, Alessandra
Journal Title
Journal ISSN
Volume Title
Publisher
C l i n i c a l a n d E x p e r i m e n t a l O b s t e t r i c s & G y n e c o l o g y
Abstract
Objective: This review aimed to investigate and summarize the current evidence on fertility-sparing options in cancer patients. Mechanism: Fertility preservation methods are becoming popular through
the improved prognosis of cancer patients at a younger age and early
diagnostic tools. However, currently, more and more women are
suffering from iatrogenic ovarian failure and fertility loss because of
cancer treatment. Most treatments have been used for hematological malignancies, but different gynecological cancers can be eligible.
Findings in brief : Fertility preserving strategies such as oocyte and embryo cryopreservation, ovarian tissue preservation, ovarian transposition, and aspiration of ovarian follicles are the methods that could
be suggested to the patients. The current knowledge supports oocyte
and embryo cryopreservation as feasible, safe, and effective treatment approaches for cancer patients seeking fertility preservation.
Conclusions: Robust evidence is still needed to prove the effectiveness
of cryopreservation of the ovarian tissue and ovarian follicle aspiration approaches since these techniques are still in early their steps.
Description
Citation
Karakaş, S., Kaya, C., Schäfer, S. D., Mikuš, M., Terzic, M., Abdullaev, B., & Andrisani, A. (2021). Fertility-sparing in cancer patients. Clinical and Experimental Obstetrics &Amp; Gynecology, 48(4), 787. https://doi.org/10.31083/j.ceog4804126
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States
